-+ 0.00%
-+ 0.00%
-+ 0.00%

PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial

PUBT·04/28/2026 12:15:41
Listen to the news
PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial
  • PRF Technologies received FDA clearance for IND application for OcuRing-K, enabling Phase II trial in cataract surgery patients.
  • Multi-center US study start-up underway, with enrollment expected to begin in H2 2026.
  • OcuRing-K is sustained-release intraocular ring delivering ketorolac via single intraoperative application.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604280800PRIMZONEFULLFEED9707712) on April 28, 2026, and is solely responsible for the information contained therein.